中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 9
Sep.  2011

Risk factors of gallbladder polyps becoming malignant: a meta-analysis

  • Published Date: 2011-09-20
  • Objective A Meta-analysis was used to evaluate the risk factors of gallbladder polyps which became malignant, and discuss the indications of prophylactic cholecystectomy.Methods According to the included criteria, fifteen case-control studies of this topic were enrolled in this analysis.The detail about the trial design, characters of the subjects and results of the studies were reviewed and analyzed by using RevMan 5.0 software after the quality of the included studies was assessed.Results The pooled OR of female, age over 50 yr, size over 10 mm, single polyp, sessile morphology, symptomatic polyp and associated stones were 1.51, 7.27, 54.65, 6.34, 15.79, 2.37 and 2.57 respectively.Conclusion The risk factors of malignant gallbladder polyps were female, age over 50 yr, size over 10 mm, single polyp, sessile morphology, symptomatic polyp and associated stones.

     

  • [1]Christensen AH, Ishak KG.Benign tumors and pseudo tumorsof the gallbladder:Report of 180 cases[J].Arch Pathol, 1970, 90 (5) :423-432.
    [2]邓绍庆, 周孝思, 张武, 等.胆囊息肉样病变中肿瘤和癌前病变的识别[J].中国实用外科杂志, 1992, 12 (11) :600-602.
    [3]苏铭, 王学汉.胆囊息肉样病变的诊治进展[J].中华肝胆外科杂志, 2006, 12 (12) :862-864.
    [4]Egger M, Davey Smith G, Schneider M, et al.Bias in meta-analysis detected by a simple graphical test[J].BMJ, 1997, 314 (7109) :629-634.
    [5]Koga A, Watanabe K, FukuyamaT, et al.Diagnosis and op-erative indications for polypoid lesions of the gallbladder[J].Arch Surg, 1988, 123 (1) :26-29.
    [6]Yang HL, Sun YG, Wang Z.Polypoid lesions of the gallblad-der:diagnosis and indications for surgery[J].Br J Surg, 1992, 79 (3) :227-229.
    [7]Isozaki H, OkajimaK, Ishibashi T, et al.Diagnosis and surgi-cal indications for polypoid lesions of the gallbladder[J].DigSurg, 1995, 12 (4) :215-219.
    [8]杨汉良.胆囊息肉样病变的诊断与手术指征 (附288例报告) [J].中国实用外科杂志, 1995, 15 (1) :18-20.
    [9]Terzi C, S kmen S, Se叆kin S, et al.Polypoid lesions of thegallbladder:Report of 100 cases with specialreference to op-erative indications[J].Surgery, 2000, 127 (6) :622-627.
    [10]刘民生, 刘会周, 陆文煜.胆囊息肉样病变207例的治疗[J].中华普通外科杂志, 2000, 15 (6) :376-376.
    [11]Yeh CN, Jan YY, Chao TC, et al.Laparoscopic cholec-ys-tectomy for polypoid lesions of the gallbladder:aclinicopatho-logic study[J].Surg Laparosc Endosc Percutan Tech, 2001, 11 (3) :176-181.
    [12]乔鸥.122例胆囊息肉病理与临床表现的对比分析[J].临床外科杂志, 2002, 10 (z1) :126-127.
    [13]李小毅, 郑朝纪, 陈杰, 等.胆囊息肉样病变的诊治[J].中国医学科学院学报, 2003, 25 (6) :679-693.
    [14]宋念, 周文凯, 钱正宇, 等.胆囊息肉样病变的手术指征探讨[J].现代临床医学, 2006, 32 (1) :3-5.
    [15]Park JK, Yoon YB, Kim YT, et al.Management strategiesfor gallbladder polyps:Is it possible to predict malignant gall-bladder polyps[J].Gut Liver, 2008, 2 (2) :88-94.
    [16]但震宇, 耿小乎, 梁久银, 等.严格胆囊息肉样病变的手术指征[J].国际外科学杂志, 2008, 35 (4) :232-234.
    [17]Kwon W, Jang JY, Lee SE, et al.Clinicopathologic features ofpolypoid lesions of the gallbladder and risk factors of gallbladdercancer[J].J Korean Med Sci, 2009, 24 (3) :481-487.
    [18]张光涛.胆囊息肉样病变125例临床分析[D].福建:福建医科大学, 2009.
    [19]贾庆安, 马经伟, 郑振兴, 等.胆囊隆起样病变的临床病理分析[J].宁夏医科大学学报, 2010, 32 (2) :268-270.
    [20]Csendes A, Burgos AM, Csendes P, et al.Late follow-upof polypoid lesions of the gallbladder smaller than 10 mm[J].Ann Surg, 2001, 234 (5) :657-660.
    [21]Moriguchi H, Tazawa J, Hayashi Y, et al.Natural history ofpolypoid lesions in the gall bladder[J].Gut, 1996, 39 (6) :860-862.
    [22]Kubota K, Bandai Y, Noie T, et al.How should polypoid le-sions of the gallbladder be treated in the era of laparoscopiccholecystectomy[J].Surgery, 1995, 117 (5) :481-487.
    [23]Albores-Saavedra J, Vardaman CJ, Vuitch F.Non-neo-plastic poly lesions and adenomas of the gallbladder[J].Pathol Annu, 1993, 28 (1) :145-177.
    [24]Kozuka S, Tsubone M, Yasui A, et al.Relation of adenomato carcinoma in the gallbladder[J].Cancer, 1982, 50 (10) :2226-2234.
    [25]Giovannucci E, Colditz GA, Stampfer MJ.A meta-analysisof cholecystectomy and risk of colorectal cancer[J].Gastro-enterology, 1993, 105 (1) :130-141.
    [26] 施伟斌.原发性胆囊癌发病危险因素流行病学分析[D].浙江:温州医学院, 2007.
    [27]Okamoto M, Okamoto H, KitaharaF, et al.Ultrasonographicevidence of association of polyps and stones with gallbladdercancer[J].Am J Gastroenterol, 1999, 94 (2) :446-450.
    [28]Tsoraides SS, ChaAI, Crawford DL.Postcholecystectomy bil-iary symptoms[J].J Surg Educ, 2007, 64 (4) :228-233.
  • Relative Articles

    [1]Xu GUO, Hao WU. Research advances in the diagnosis and treatment of hepatic vein occlusion-type Budd-Chiari syndrome[J]. Journal of Clinical Hepatology, 2024, 40(1): 13-18. doi: 10.12449/JCH240102
    [2]Jing YANG, Suxin LI, Yuehui ZHANG, Luhao LI, Zhaochen LIU, Dongqi SHEN, Xiaowei DANG. Effect of metformin on liver fibrosis in a mouse model of Budd-Chiari syndrome[J]. Journal of Clinical Hepatology, 2022, 38(9): 2034-2039. doi: 10.3969/j.issn.1001-5256.2022.09.017
    [3]Cui ZHOU, Bo SHEN, Ying QU, Lungen LU. Current status of the clinical management of Budd-Chiari syndrome[J]. Journal of Clinical Hepatology, 2022, 38(7): 1474-1476. doi: 10.3969/j.issn.1001-5256.2022.07.005
    [4]Pang RunHua, Zhu YaQing. Hepatic dysplastic nodules with Budd-Chiari syndrome misdiagnosed as hepatocellular carcinoma: A case report[J]. Journal of Clinical Hepatology, 2020, 36(5): 1115-1116. doi: 10.3969/j.issn.1001-5256.2020.05.033
    [5]Wang LiBo, Sun YuLing. Establishment of Budd-Chiari syndrome models and related research advances[J]. Journal of Clinical Hepatology, 2020, 36(4): 908-911. doi: 10.3969/j.issn.1001-5256.2020.04.044
    [6]Wu KaiMin, Cao Shan, Zhang GuoYan, Chen GuoDong, Su Lin, Wang ZhiFeng, Liu YuLan. A case of paroxysmal nocturnal hemoglobinuria with Budd-Chiari syndrome as the first manifestation[J]. Journal of Clinical Hepatology, 2018, 34(10): 2197-2199. doi: 10.3969/j.issn.1001-5256.2018.10.028
    [7]Yu Hong, Sun DianXing, Liang ZhiHui, Li HaiJun, Yang XinYing, Kang FuBiao. Diagnosis and interventional therapy for Budd-Chiari syndrome secondary to hepatic venous obstruction[J]. Journal of Clinical Hepatology, 2017, 33(7): 1340-1341. doi: 10.3969/j.issn.1001-5256.2017.07.028
    [8]Zhang WenWen, Qi XingShun, Guo XiaoZhong. Significance of factor Ⅱ G20210A mutation in Budd-Chiari syndrome and portal vein thrombosis[J]. Journal of Clinical Hepatology, 2015, 31(2): 310-314. doi: 10.3969/j.issn.1001-5256.2015.02.043
    [9]Xiao PeiRui, Lin XinYing, Guo ChengHao, Bian JianChao, Yang XiaoXia, Wang JinBiao. Study of correlation between the geographical distribution of Budd-Chiari syndrome with iodine content in drinking water[J]. Journal of Clinical Hepatology, 2011, 27(2): 130-133.
    [10]Peng Tao, Zhang GuoYan, Liu YuLan. Identification of Budd-Chiari syndrome, hepatic sinusoidal obstruction syndrome and hepatic cirrhosis[J]. Journal of Clinical Hepatology, 2011, 27(10): 1022-1026+1031.
    [11]Meng QingYi, Sun NianFeng, Wang RuiHua, Liu ZhaoXuan, Li Bo, Wang ZhongHao. Interventional treatment for Budd-Chiari syndrome:reports of 883 cases[J]. Journal of Clinical Hepatology, 2011, 27(2): 127-129.
    [12]Wang Kun, Yu ZhenHai, Li GuangXin, Zhang ShuGuang, Qin ShiYong, Wang MingHai, Ruan ZhangLe. The application of interventional therapy for Budd-Chiari syndrome[J]. Journal of Clinical Hepatology, 2011, 27(2): 123-126.
    [13]Li ChunMin, Bian Ce, Wang ZhongHao. Spontanously healing of Budd-Chiari syndrome:a case report[J]. Journal of Clinical Hepatology, 2011, 27(2): 198+20.
    [14]Wang ZhongHao, Li ChunMin, Lu WenXian, Bi Wei. Mesojugularl shunt applying in Budd-Chiari syndrome:two cases report[J]. Journal of Clinical Hepatology, 2011, 27(2): 194-195+197.
    [15]Wang ZhongHao, Li ChunMin. Mesocavoatrial shunt healing of type Ⅱ Budd-Chiari syndrome:a case report[J]. Journal of Clinical Hepatology, 2011, 27(2): 196-197.
    [16]Wang ZhongHao, Li ChunMin, Li Zhen, Bian Ce, Gu YongQuan, Yu HengXi, Chen Bing. Evolution and prospects of Budd-Chiari syndrome[J]. Journal of Clinical Hepatology, 2011, 27(2): 113-115.
    [17]Zheng YueHong, Shao Jiang, Song XiaoJun, Ren HuaLiang, Ye Wei, Liu Bao, Wu JiDong, Li YongJun, Liu ChangWei, Lu Xin, Sang XinTing. New surgical therapy for Budd-Chiari syndrome through a transabdominal approach[J]. Journal of Clinical Hepatology, 2011, 27(2): 201-202.
  • 加载中
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 3.2 %FULLTEXT: 3.2 %META: 94.0 %META: 94.0 %PDF: 2.8 %PDF: 2.8 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 3.2 %其他: 3.2 %上海: 2.2 %上海: 2.2 %北京: 3.5 %北京: 3.5 %十堰: 0.3 %十堰: 0.3 %南宁: 0.3 %南宁: 0.3 %吉林: 0.3 %吉林: 0.3 %宣城: 0.3 %宣城: 0.3 %广州: 0.3 %广州: 0.3 %张家口: 3.2 %张家口: 3.2 %杭州: 0.3 %杭州: 0.3 %武汉: 0.3 %武汉: 0.3 %漯河: 0.3 %漯河: 0.3 %石家庄: 0.9 %石家庄: 0.9 %芒廷维尤: 42.0 %芒廷维尤: 42.0 %莫斯科: 0.6 %莫斯科: 0.6 %衡水: 0.6 %衡水: 0.6 %西宁: 40.4 %西宁: 40.4 %长春: 0.9 %长春: 0.9 %其他上海北京十堰南宁吉林宣城广州张家口杭州武汉漯河石家庄芒廷维尤莫斯科衡水西宁长春

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (3807) PDF downloads(679) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return